Solios Diagnostics innovates healthcare with fast, eco-friendly diagnostic devices, simplifying testing for infectious diseases
Solios Diagnostics caters to legal manufacturers across various sectors, including human, veterinary, environmental, and food safety diagnostics. The device is universally applicable, user-friendly, and designed to function outside a lab setting. It significantly cuts down testing time and reduces sample material usage. Moreover, commitment to the environment is evident in using bioplastics in the device’s design.
The product addresses critical issues in the current diagnostics market, where traditional lab-based diagnostics are often costly and time-consuming. Additionally, existing rapid testing methods contribute to a significant amount of waste. In contrast, the device is designed for simplicity and efficiency. It allows users to insert a sample and quickly get results, readable by the naked eye, within minutes. The device’s standout feature is its ability to facilitate accurate testing at home or the point of need without requiring additional devices, infrastructure, or specialized training. This is particularly beneficial in regions with limited access to lab diagnostics, offering a practical solution even in low-income areas.
The competitors are companies like Senzo, which offers point-of-care PCR solutions, and others that utilize AI and data analytics for at-home testing. The Solios Diagnostics team believes in the uniqueness of their approach. Many competitors struggle with issues of accessibility and consistency, but Solios Diagnostics’ focus remains on overcoming these barriers by using analog technology for accurate and accessible testing.
Solios Diagnostics progressed beyond the ideation stage to prototyping, with extensive testing and receiving Letters of Intent (LOIs). Their team is united by a common purpose to revolutionize the diagnostics landscape, with plans for recruitment, product development, customer acquisition, increased marketing visibility, and clinical studies.